Literature DB >> 10417563

Deep venous thrombosis in peripheral vascular disease.

G Libertiny1, L Hands.   

Abstract

BACKGROUND: This prospective study aimed to determine the prevalence of lower limb deep venous thrombosis in patients with peripheral vascular disease (PVD).
METHODS: Some 136 patients admitted for arteriography, angioplasty or arterial reconstruction with limiting claudication (n = 72), ischaemic rest pain (n = 26) or gangrene (n = 38) and 40 control subjects admitted for general surgical procedures but without evidence of PVD were screened with colour duplex ultrasonography for the presence of venous thrombosis in the lower limb deep veins before any surgical or radiological procedures were undertaken. Patient age, the ankle : brachial pressure index (ABPI) and the presence of other risk factors for venous thromboembolism were also recorded.
RESULTS: Venous thrombosis was found in 27 of 136 patients with PVD and two of 40 control patients (P = 0.03). Logistic regression analysis demonstrated that decreasing ABPI independently contributed to an increased risk of deep venous thrombosis.
CONCLUSION: There was a high prevalence of venous thrombosis among patients with PVD which was related to the severity of the ischaemia. Presented to the South West Vascular Surgeons Meeting in Newport, UK, March 1998

Entities:  

Mesh:

Year:  1999        PMID: 10417563     DOI: 10.1046/j.1365-2168.1999.01129.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  7 in total

1.  Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.

Authors:  Aneel A Ashrani; Michel K Barsoum; Daniel J Crusan; Tanya M Petterson; Kent R Bailey; John A Heit
Journal:  Thromb Res       Date:  2015-04-11       Impact factor: 3.944

Review 2.  AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score.

Authors:  Nasir Shariff; Abdul Aleem; Mukesh Singh; Yuan Z Li; Stacey J Smith
Journal:  J Atr Fibrillation       Date:  2012-10-06

3.  Atherosclerosis and Its Impact on the Outcomes of Patients with Deep Venous Thrombosis.

Authors:  Karsten Keller; Jürgen H Prochaska; Meike Coldewey; Sebastian Göbel; Volker H Schmitt; Omar Hahad; Alexander Ullmann; Markus Nagler; Heidrun Lamparter; Christine Espinola-Klein; Thomas Münzel; Philipp S Wild
Journal:  Life (Basel)       Date:  2022-05-14

4.  Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.

Authors:  David Rb Herlihy; Matthew Thomas; Quoc H Tran; Vikram Puttaswamy
Journal:  Cochrane Database Syst Rev       Date:  2020-07-21

5.  Inflammatory plasma markers and risk for venous thromboembolism.

Authors:  Signy V Sveinsdottir; Peter J Svensson; Gunnar Engström
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

6.  Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer.

Authors:  Shruti Chaturvedi; Surbhi Sidana; Paul Elson; Alok A Khorana; Keith R McCrae
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

7.  Potential Association between Distal Deep Vein Thrombosis and Asymptomatic Atherosclerosis.

Authors:  Angelo Adamo; Luca Spiezia; Valle Fabio Dalla; Giampiero Avruscio; Paolo Simioni
Journal:  TH Open       Date:  2021-12-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.